The all-electric Jaguar I-PACE has achieved a five-star Euro NCAP safety rating, confirming it as one of the safest vehicles on the road.
Jaguar’s first electric performance SUV scored 91% for adult occupant protection, 81% for child occupant protection and 81% for safety assist. I-PACE scored maximum points for both the side barrier impact and the more severe side pole test, with good protection of all critical body areas.
This latest result means all three members of Jaguar’s PACE SUV family, E-PACE, F-PACE and I-PACE, have the maximum five-star Euro NCAP rating, demonstrating Jaguar’s commitment to engineering some of the safest family cars. I-PACE is the tenth consecutive model from Britain’s biggest vehicle manufacturer to receive five stars.
The I-PACE’s lightweight aluminium body structure delivers inherently high levels of stiffness, and when combined with the integral battery pack – protected by a structural aluminium frame – delivers the highest torsional rigidity of any Jaguar yet, at 36kNm per degree. Highlights of the body design include industry-first use of aluminium forgings, and Jaguar-first applications of post-form heat treatment to increase the strength of the aluminium alloys used in crash-critical areas.
In addition to safety technologies, the performance SUV offers a full suite of advanced driver assistance systems including Adaptive Cruise Control with Steering Assist, Blind Spot Assist, and 360° Parking Aid.
Euro NCAP has created the five-star safety rating system to help consumers, their families and businesses compare vehicles more easily and to help them identify the safest choice for their needs.
The safety rating is determined from a series of vehicle tests, designed and carried out by Euro NCAP. These tests represent, in a simplified way, important real life accident scenarios that could result in injured or killed car occupants or other road users. A high number of stars shows the test result was good, but also that safety equipment on the tested model is readily available to all consumers in Europe.